Advanced search
Publication Cover
Journal of Asthma Volume 59, 2022 - Issue 5
Submit an article Journal homepage
447
Views
9
CrossRef citations to date
0
Altmetric
Treatment

Results in clinical practice in the treatment of severe eosinophilic asthma with mepolizumab: a real-life study

Ana Isabel Enríquez-Rodrígueza Department of Pulmonary Medicine, Hospital Universitario Central de Asturias, ISPA, Oviedo, SpainCorrespondence[email protected]
, PhD,
Tamara Hermida Valverdea Department of Pulmonary Medicine, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain
, MD,
Pedro Romero Álvareza Department of Pulmonary Medicine, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain
, MD,
Francisco Julián López-Gonzáleza Department of Pulmonary Medicine, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain
, PhD,
Jose Antonio Gullón Blancob Department of Pulmonary Medicine, Hospital Universitario de San Agustín, Avilés, Spain
, PhD,
Ana Rosa Expósito Villegasc Department of Pulmonary Medicine, Hospital Universitario de Cabueñes, Gijón, Spain
, MD,
María José Escobar Fernándezc Department of Pulmonary Medicine, Hospital Universitario de Cabueñes, Gijón, Spain
, MD,
Ana María Beristáin Urquizad Department of Allergy Medicine, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain
, MD,
Miguel Ángel Alonso Fernándeze Department of Pulmonary Medicine, Hospital Vital Álvarez Buylla, Mieres, Spain
, MD,
Margarita Gutiérrez Rodríguezf Department of Pulmonary Medicine, del Hospital Carmen y Severo Ochoa, Cangas del Narcea, Spain
, MD,
Gema Castaño De las Pozasg Department of Pulmonary Medicine, Hospital Público Comarcal de Jarrio, Jarrio, Spain
, MD,
Jennifer Jiménez Pérezh Department of Pulmonary Medicine, Hospital Francisco Grande Covián, Arriondas, Spain
, MD,
Roberto Fernández Melladoi Department of Pulmonary Medicine, Hospital Valle del Nalón, Langreo, Spain
, MD,
Marta María García Clementea Department of Pulmonary Medicine, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain
, PhD &
Pere Casan Claraj Department of Pulmonary Medicine, Hospital Universitario Central de Asturias-Universidad de Oviedo, ISPA-FINBA, Oviedo, Spain
, PhD show all
Pages 1005-1011 | Received 15 Oct 2020, Accepted 27 Feb 2021, Published online: 27 Mar 2021

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Stephanie Korn, Katrin Milger, Dirk Skowasch, Christian Schulz, Cordula Mohrlang, Martin Wernitz, Thomas Paulsson, Michael Hennig & Roland Buhl. (2023) Real-World Experience on the Use of Mepolizumab from the Severe Asthma Registry of the German Asthma Net (MepoGAN-Study). Journal of Asthma and Allergy 16, pages 541-552.
Read now
Javier Domínguez-Ortega, Daniel Laorden, Francisca Vílchez-Sánchez, David Bañas-Conejero & Santiago Quirce. (2023) Cost-effectiveness and resource use analysis of patients with asthma before and after treatment with mepolizumab in a real-life setting. Journal of Asthma 0:0, pages 1-9.
Read now
Andriana I Papaioannou, Evangelia Fouka, Konstantinos Bartziokas, Maria Kallieri, Angelos Vontetsianos, Konstantinos Porpodis, Nikoletta Rovina, Stelios Loukides & Petros Bakakos. (2023) Defining response to therapy with biologics in severe asthma: from global evaluation to super response and remission. Expert Review of Respiratory Medicine 17:6, pages 481-493.
Read now

Articles from other publishers (6)

Ronald Strauss, Hannah Leflein, Anna Kolesar & Jeffrey Hammel. (2023) Long-Term Efficacy and Safety Among Patients With Severe Eosinophilic Asthma Treated With Mepolizumab and Its Effect on Small Airways. The Journal of Allergy and Clinical Immunology: In Practice 11:12, pages 3670-3679.e2.
Crossref
Shijie Li, Shijie Wang, Eric Fordjour, Yaoji Liang, Xuelian Wang, Yonghao Ye, Zhonghu Bai, Yankun Yang & Yongqi Chen. (2023) Development and characterization of anti-IL-5 monoclonal antibody Fab fragment for blocking IL-5/IL-5Rα binding. International Immunopharmacology 124, pages 111032.
Crossref
Marianne Baastrup Soendergaard, Susanne Hansen, Anne-Sofie Bjerrum, Ole Hilberg, Sofie Lock-Johansson, Kjell Erik Julius Håkansson, Truls Sylvan Ingebrigtsen, Claus Rikard Johnsen, Linda Makowska Rasmussen, Anna von Bülow, Karin Dahl Assing, Johannes Martin Schmid, Charlotte Suppli Ulrik & Celeste Porsbjerg. (2022) Complete response to anti-interleukin-5 biologics in a real-life setting: results from the nationwide Danish Severe Asthma Register. ERJ Open Research 8:4, pages 00238-2022.
Crossref
Hale ATEŞ, Kurtuluş AKSU, İlkay KOCA KALKAN, Musa TOPEL, Senay DEMİR, Selma YESİLKAYA & Sakine NAZİK BAHCECİOGLU. (2022) Evaluation of real-life data in patients with severe eosinophilic asthma treated with mepolizumabMepolizumab ile tedavi edilen ağır eozinofilik astımlı hastalarda gerçek yaşam verilerinin değerlendirilmesi. Journal of Medicine and Palliative Care 3:3, pages 275-279.
Crossref
Christian Domingo Ribas, Teresa Carrillo Díaz, Marina Blanco Aparicio, Eva Martínez Moragón, David Banas Conejero, M. Guadalupe Sánchez Herrero, Mariana Muñoz, Héctor Cabrerizo, Antonio Valero, Ebymar Arismendi, Irina Bobolea, Gemma López, Celia Pinedo, Francisco Javier González-Barcala, Purificación Pérez-López-Corona, Jacinto Ramos-González, Javier Martín-Puentes, Gregorio Soto-Campos, Francisco Pérez-Grimaldi, Inmaculada Lluch, Juan Luis García-Rivero, Celia Gutierrez-Villegas, Idoia Salinas-Garrido, Cleofé Fernández-Aracil, Luis Puente-Maestu, Walther Iván Girón, Ángela Gómez-Sacristán, Miguel Díaz-Palacios, Ethel Ibáñez, Irene De Lorenzo, Ana Sogo, Daniel Ross-Monserrate, Elena Prina, Eusebi Chiner-Vives, Sandra Vañes, Rocío Díaz-Campos, Ismael García-Moguel, Carmen Montero, María Fernández-Marrube, Tamara Hermida-Valverde, Anaís Enríquez, Nuria Marina-Malanda, Ana Gómez-Larrauri, Antonio García-Dumpiérrez, Rodolfo Castillo-Sainz, Nancy Ortega, Lourdes Almeida, Luis Cabanes, Santiago Quirce, Javier Dominguez-Ortega, David Romero, Irene Hernández, Daniel Laorden, Carolina Cisneros, Antolín López-Viña, Andrea Trisán, Teresa Caruana-Careaga, Ana Gómez-Bastero & Lucía Marín-Barrera. (2021) REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study. Drugs 81:15, pages 1763-1774.
Crossref
Luigino Calzetta, Marina Aiello, Annalisa Frizzelli, Giuseppina Bertorelli, Paola Rogliani & Alfredo Chetta. (2021) Oral Corticosteroids Dependence and Biologic Drugs in Severe Asthma: Myths or Facts? A Systematic Review of Real-World Evidence. International Journal of Molecular Sciences 22:13, pages 7132.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.